BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matz M, Lorkowski C, Fabritius K, Wu K, Rudolph B, Frischbutter S, Brakemeier S, Gaedeke J, Neumayer H, Mashreghi M, Budde K. The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells. Transplant Immunology 2016;39:18-24. [DOI: 10.1016/j.trim.2016.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Yu MY, Kwon S, Moon JJ, Kim YC, Song EY, Lee H, Moon KC, Ha J, Kim DK, Han SW, Kim GH, Kim YS, Yang SH. Role of the IL-33/ST2 pathway in renal allograft rejection. Exp Cell Res 2021;405:112705. [PMID: 34166678 DOI: 10.1016/j.yexcr.2021.112705] [Reference Citation Analysis]
2 Kwiatkowska E, Domański L, Bober J, Safranow K, Szymańska-Pasternak J, Sulecka A, Pawlik A, Ciechanowski K, Kwiatkowski S. Urinary IL-8 is a marker of early and long-term graft function after renal transplantation. Ren Fail 2017;39:484-90. [PMID: 28494217 DOI: 10.1080/0886022X.2017.1323644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
3 Thomas P, Hisgen P, Kiefer H, Schmerwitz U, Ottersbach A, Albrecht D, Summer B, Schinkel C. Blood cytokine pattern and clinical outcome in knee arthroplasty patients: comparative analysis 5 years after standard versus "hypoallergenic" surface coated prosthesis implantation. Acta Orthop 2018;89:646-51. [PMID: 30372661 DOI: 10.1080/17453674.2018.1518802] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
4 García-Covarrubias L, Cedillo JS, Morales L, Fonseca-Sanchez MA, García-Covarrubias A, Villanueva-Ortega E, Hernández C, Diliz H, Reding-Bernal A, Soto V, Queipo G. Interleukin 8 Is Overexpressed in Acute Rejection in Kidney Transplant Patients. Transplant Proc 2020;52:1127-31. [PMID: 32307138 DOI: 10.1016/j.transproceed.2020.02.005] [Reference Citation Analysis]